SLC2A1 and in situ carcinoma: More interestingly, it was noted that carcinoma in situ always showed GLUT-1 overexpression (n = 29) in the three patient groups, with a statistically significant difference compared to associated infiltrative contingent (p: 2.60 × 10−6, data not shown) (Figure 4A).